Bio-Techne (TECH) Debt Ratio (2014 - 2026)
Bio-Techne (TECH) posted quarterly Debt Ratio of 0.08 for Q1 2026, down 37.17% year-over-year from 0.12 in Q1 2025, and down 23.92% quarter-over-quarter from 0.1 in Q4 2025.
Analysis
Bio-Techne (TECH) Debt Ratio (2014 - 2026) Analysis & Trends
Bio-Techne's Debt Ratio history runs 13 years deep, the most recent figure standing at 0.08 for Q1 2026.
- In Q1 2026, Debt Ratio fell 37.17% year-over-year to 0.08; the TTM figure through Mar 2026 stood at 0.08 (down 37.17% YoY), while the FY2025 annual figure was 0.14, up 14.65% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.08, down from 0.1 in the prior quarter.
- The five-year high for Debt Ratio was 0.16 in Q4 2023, with the low at 0.08 in Q1 2026.
- The 5-year median for Debt Ratio is 0.12 (2024), against an average of 0.12.
- The sharpest annual moves came in 2023 and 2026: Debt Ratio surged 93.43% in 2023, then slumped 37.17% in 2026.
- Bio-Techne's Debt Ratio stood at 0.08 in 2022, then soared by 93.43% to 0.16 in 2023, then tumbled by 31.37% to 0.11 in 2024, then declined by 8.26% to 0.1 in 2025, then fell by 23.92% to 0.08 in 2026.
- Business Quant data shows TECH's Debt Ratio at 0.08 in Q1 2026, 0.1 in Q4 2025, and 0.12 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.32 Bn | 131.47 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.67 Bn | 77.67 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 63.51 Bn | 58.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 0.05 |
| 5 | Revolution Medicines | 44.17 Bn | 44.17 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 0.12 |
| 7 | Alnylam Pharmaceuticals | 35.25 Bn | 31.94 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 0.47 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 0.26 |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 0.08 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.08 |
| Mar 31, 2026 | 0.08 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.11 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | 0.16 |
| Sep 30, 2023 | 0.16 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.14 |
| Dec 31, 2022 | 0.08 |
| Sep 30, 2022 | 0.12 |
| Jun 30, 2022 | 0.11 |
| Mar 31, 2022 | 0.11 |
| Dec 31, 2021 | 0.12 |
| Sep 30, 2021 | 0.13 |